BR112022004797A2 - Optimized tetrahydrocannabinolic acid (thca) synthase polypeptides - Google Patents

Optimized tetrahydrocannabinolic acid (thca) synthase polypeptides

Info

Publication number
BR112022004797A2
BR112022004797A2 BR112022004797A BR112022004797A BR112022004797A2 BR 112022004797 A2 BR112022004797 A2 BR 112022004797A2 BR 112022004797 A BR112022004797 A BR 112022004797A BR 112022004797 A BR112022004797 A BR 112022004797A BR 112022004797 A2 BR112022004797 A2 BR 112022004797A2
Authority
BR
Brazil
Prior art keywords
tetrahydrocannabinolic acid
thca
optimized
engineered variants
methods
Prior art date
Application number
BR112022004797A
Other languages
Portuguese (pt)
Inventor
Andrew Horwitz
Darren Platt
Jeff Ubersax
Jeff Wong
Original Assignee
Demetrix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Demetrix Inc filed Critical Demetrix Inc
Publication of BR112022004797A2 publication Critical patent/BR112022004797A2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/42Hydroxy-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y121/00Oxidoreductases acting on X-H and Y-H to form an X-Y bond (1.21)
    • C12Y121/03Oxidoreductases acting on X-H and Y-H to form an X-Y bond (1.21) with oxygen as acceptor (1.21.3)
    • C12Y121/03007Tetrahydrocannabinolic acid synthase (1.21.3.7)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

polipeptídeos otimizados de ácido tetra-hidrocanabinólico (thca) sintase. a presente divulgação fornece variantes manipuladas de um polipeptídeo de ácido tetra-hidrocanabinólico sintase (thcas) que compreende uma sequência de aminoácidos da seq id no:44 com uma ou mais substituições de aminoácido, ácidos nucleicos compreendendo sequências nucleotídicas que codificam as referidas variantes manipuladas, métodos de produção de células hospedeiras modificadas compreendendo os referidos ácidos nucleicos, células hospedeiras modificadas que expressam as referidas variantes manipuladas, métodos de produção de canabinoides ou de derivados canabinoides, e métodos de triagem de variantes manipuladas do polipeptídeo de ácido tetra-hidrocanabinólico sintase (thcas).optimized tetrahydrocannabinolic acid (thca) synthase polypeptides. the present disclosure provides engineered variants of a tetrahydrocannabinolic acid synthase (thcas) polypeptide comprising an amino acid sequence of seq id no:44 with one or more amino acid substitutions, nucleic acids comprising nucleotide sequences encoding said engineered variants, methods of producing modified host cells comprising said nucleic acids, modified host cells expressing said engineered variants, methods of producing cannabinoids or cannabinoid derivatives, and methods of screening engineered variants of tetrahydrocannabinolic acid synthase (thcas) polypeptide ).

BR112022004797A 2019-09-18 2020-09-17 Optimized tetrahydrocannabinolic acid (thca) synthase polypeptides BR112022004797A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962902300P 2019-09-18 2019-09-18
PCT/US2020/051261 WO2021055597A1 (en) 2019-09-18 2020-09-17 Optimized tetrahydrocannabinolic acid (thca) synthase polypeptides

Publications (1)

Publication Number Publication Date
BR112022004797A2 true BR112022004797A2 (en) 2022-06-21

Family

ID=72744852

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022004797A BR112022004797A2 (en) 2019-09-18 2020-09-17 Optimized tetrahydrocannabinolic acid (thca) synthase polypeptides

Country Status (9)

Country Link
EP (1) EP4031657A1 (en)
JP (1) JP2022548904A (en)
CN (1) CN115038786A (en)
AU (1) AU2020349513A1 (en)
BR (1) BR112022004797A2 (en)
CA (1) CA3152803A1 (en)
IL (1) IL291328A (en)
MX (1) MX2022003203A (en)
WO (1) WO2021055597A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3130763A1 (en) 2019-02-25 2020-09-03 Ginkgo Bioworks, Inc. Biosynthesis of cannabinoids and cannabinoid precursors
WO2023168266A2 (en) * 2022-03-02 2023-09-07 Genomatica, Inc. Flavin-dependent oxidases having cannabinoid synthase activity

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003287028B2 (en) 2002-10-04 2008-09-04 E.I. Du Pont De Nemours And Company Process for the biological production of 1,3-propanediol with high yield
CA2709107A1 (en) 2007-12-13 2009-06-18 Danisco Us Inc. Compositions and methods for producing isoprene
MY153871A (en) 2008-04-23 2015-03-31 Danisco Us Inc Isoprene synthase variants for improved microbial production of isoprene
CN102791848B (en) 2008-07-02 2017-11-10 丹尼斯科美国公司 For producing the method and composition of the isoprene without C5 hydrocarbon in the case where removing coupling condition and/or safe operating range
JP7198555B2 (en) * 2017-04-27 2023-01-04 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Microorganisms and methods for producing cannabinoids and cannabinoid derivatives
EP3652327A4 (en) * 2017-07-12 2021-04-21 Biomedican, Inc. Production of cannabinoids in yeast
CA3123182A1 (en) * 2017-12-14 2019-06-20 Medicinal Genomics Corporation Methods and kits for classifying cannabinoid production in cannabis plants
WO2020069214A2 (en) * 2018-09-26 2020-04-02 Demetrix, Inc. Optimized expression systems for producing cannabinoid synthase polypeptides, cannabinoids, and cannabinoid derivatives

Also Published As

Publication number Publication date
CA3152803A1 (en) 2021-03-25
IL291328A (en) 2022-05-01
EP4031657A1 (en) 2022-07-27
CN115038786A (en) 2022-09-09
JP2022548904A (en) 2022-11-22
AU2020349513A1 (en) 2022-05-05
MX2022003203A (en) 2022-06-08
WO2021055597A1 (en) 2021-03-25

Similar Documents

Publication Publication Date Title
BR112021023218A2 (en) Optimized cannabinoid synthase polypeptides
BR112017022298A2 (en) geranylgeranyl pyrophosphate synthase
Caliskan et al. Conditional switch between frameshifting regimes upon translation of dnaX mRNA
BR112022004797A2 (en) Optimized tetrahydrocannabinolic acid (thca) synthase polypeptides
BR112016020517A2 (en) lipid production method using ss-ketoacyl acp synthase
BR112017017884A2 (en) binding triggered transcriptional switches and methods of using them
BRPI0611909A2 (en) improved amino acid and metabolite biosynthesis
ES2667718T3 (en) Methods and compositions for producing hydrocarbons
ES2531135T3 (en) Phytases, nucleic acids that encode them and methods for their production and use
BR112012006501A8 (en) POLYPEPTIDES AND USES THEREOF
UY31875A (en) NEW GENES INVOLVED IN BIOSYNTHESIS
Hoffmann et al. Expanding the archaellum regulatory network–the eukaryotic protein kinases ArnC and ArnD influence motility of Sulfolobus acidocaldarius
BR9909258A (en) Expression of trehalose biosynthetic genes in plants
AR053259A1 (en) WHEAT WITH NEW ALMIDON AND METHOD TO PRODUCE IT
MX2010003055A (en) Novel avian cytokines and genetic sequences encoding same.
BR112016025898A2 (en) Drimenol Synthases and Method for Producing Drimenol
BR112018012055A2 (en) recombinant transglutaminase (tg) substrate, in vitro method for labeling a protein of interest, pharmaceutical or diagnostic composition and diagnostic kit
BR112016011095A2 (en) MODIFIED ENDOLISIN EL188 SEQUENCE
BR112021023769A2 (en) gene for parthenogenesis
BR112016011091A2 (en) modified endolysin sequence kz144
MX2020001058A (en) Fusion tags for recombinant protein expression.
BR112017022076A2 (en) Mesothelin-variant III fusions of epidermal growth factor receptor and methods of use thereof
Sugden et al. The Dictyostelium prestalk inducer differentiation-inducing factor-1 (DIF-1) triggers unexpectedly complex global phosphorylation changes
BR112016025905A2 (en) drimenol synthases ii
BR112012033396A2 (en) Polypeptide having swollenin activity and its uses.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]